title: Nuclear epidermal growth factor receptor (EGFR) interacts with signal transducer and activator of transcription 5 (STAT5) in activating Aurora-A gene expression.
abstract: Loss of the maintenance of genetic material is a critical step leading to tumorigenesis. It was reported that overexpression of Aurora-A and the constitutive activation of the epidermal growth factor (EGF) receptor (EGFR) are implicated in chromosome instability. In this study, we examined that when cells treated with EGF result in centrosome amplification and microtubule disorder, which are critical for genetic instability. Interestingly, the expression of Aurora-A was also increased by EGF stimulus. An immunofluorescence assay indicated that EGF can induce the nuclear translocation of EGFR. Chromatin immunoprecipitation (ChIP) and re-ChIP assays showed significant EGF-induced recruitment of nuclear EGFR and signal transducer and activator of transcription 5 (STAT5) to the Aurora-A promoter. A co-immunoprecipitation assay further demonstrated that EGF induces nuclear interaction between EGFR and STAT5. A small interfering (si)RNA knockdown assay also showed that EGFR and STAT5 are indeed involved in EGF-increased Aurora-A gene expression. Altogether, this study proposes that the nuclear EGFR associates with STAT5 to bind and increase Aurora-A gene expression, which ultimately may lead to chromosome instability and tumorigenesis. The results also provide a novel linkage between the EGFR signaling pathway and overexpression of Aurora-A in tumorigenesis and chromosome instability.
authors.affiliation: Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan 70101, Taiwan. lyhung@mail.ncku.edu.tw
authors.forename: Liang-Yi
authors.initials: LY
authors.lastname: Hung
authors.forename: Joseph T
authors.initials: JT
authors.lastname: Tseng
authors.forename: Yi-Chao
authors.initials: YC
authors.lastname: Lee
authors.forename: Weiya
authors.initials: W
authors.lastname: Xia
authors.forename: Ying-Nai
authors.initials: YN
authors.lastname: Wang
authors.forename: Min-Li
authors.initials: ML
authors.lastname: Wu
authors.forename: Yu-Hsuan
authors.initials: YH
authors.lastname: Chuang
authors.forename: Chein-Hsien
authors.initials: CH
authors.lastname: Lai
authors.forename: Wen-Chang
authors.initials: WC
authors.lastname: Chang
mesh_terms: D021581:Active Transport, Cell Nucleus; D000818:Animals; D064127:Aurora Kinases; D002460:Cell Line; D002467:Cell Nucleus / Q000378:metabolism; D018385:Centrosome / Q000187:drug effects / Q000648:ultrastructure; D043171:Chromosomal Instability / Q000187:drug effects; D006224:Cricetinae; D004815:Epidermal Growth Factor / Q000494:pharmacology; D066246:ErbB Receptors / Q000378:metabolism*; D006801:Humans; D008870:Microtubules / Q000187:drug effects / Q000648:ultrastructure; D011401:Promoter Regions, Genetic; D017346:Protein Serine-Threonine Kinases / Q000096:biosynthesis / Q000235:genetics*; D018160:Receptors, Cytoplasmic and Nuclear / Q000378:metabolism*; D050799:STAT5 Transcription Factor / Q000378:metabolism*; D015533:Transcriptional Activation
chemical_list: D018160:Receptors, Cytoplasmic and Nuclear; D050799:STAT5 Transcription Factor; D004815:Epidermal Growth Factor; D066246:ErbB Receptors; D064127:Aurora Kinases; D017346:Protein Serine-Threonine Kinases